#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study

2024/04/3007:52:04 science 1951
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study - DayDayNews #ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study - DayDayNews
2:37
* All content videos are shared, reposted and embedded from YouTube. If there is any violation or error, please contact us to delete it.

Recommended

science Latest News

Site Latest News